

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 6.36795410 |
| 2 | synaptic vesicle maturation (GO:0016188) | 6.23032205 |
| 3 | locomotory exploration behavior (GO:0035641) | 6.18377108 |
| 4 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 6.06893471 |
| 5 | vocalization behavior (GO:0071625) | 5.81893152 |
| 6 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.78948144 |
| 7 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.42767031 |
| 8 | regulation of glutamate receptor signaling pathway (GO:1900449) | 5.18390596 |
| 9 | cerebellar granule cell differentiation (GO:0021707) | 5.12366070 |
| 10 | * synaptic vesicle exocytosis (GO:0016079) | 5.08291290 |
| 11 | glutamate secretion (GO:0014047) | 5.04697497 |
| 12 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.92573409 |
| 13 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.92115759 |
| 14 | L-amino acid import (GO:0043092) | 4.90847290 |
| 15 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.88407536 |
| 16 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.88270305 |
| 17 | regulation of synapse structural plasticity (GO:0051823) | 4.76312712 |
| 18 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.75071447 |
| 19 | exploration behavior (GO:0035640) | 4.73220350 |
| 20 | protein localization to synapse (GO:0035418) | 4.72793832 |
| 21 | neuronal action potential propagation (GO:0019227) | 4.68015310 |
| 22 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 4.61141785 |
| 23 | neurotransmitter secretion (GO:0007269) | 4.57629995 |
| 24 | amino acid import (GO:0043090) | 4.48882921 |
| 25 | regulation of synaptic vesicle transport (GO:1902803) | 4.43950500 |
| 26 | dendritic spine morphogenesis (GO:0060997) | 4.41898015 |
| 27 | potassium ion homeostasis (GO:0055075) | 4.32716012 |
| 28 | synaptic transmission, glutamatergic (GO:0035249) | 4.26709376 |
| 29 | long-term memory (GO:0007616) | 4.22289972 |
| 30 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.20434737 |
| 31 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.16441962 |
| 32 | central nervous system myelination (GO:0022010) | 4.16333990 |
| 33 | axon ensheathment in central nervous system (GO:0032291) | 4.16333990 |
| 34 | potassium ion import (GO:0010107) | 4.15458876 |
| 35 | layer formation in cerebral cortex (GO:0021819) | 4.14999773 |
| 36 | positive regulation of membrane potential (GO:0045838) | 4.13959936 |
| 37 | neuron cell-cell adhesion (GO:0007158) | 4.12984615 |
| 38 | glutamate receptor signaling pathway (GO:0007215) | 4.12079703 |
| 39 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 4.08443147 |
| 40 | regulation of synapse maturation (GO:0090128) | 4.07277886 |
| 41 | neuron-neuron synaptic transmission (GO:0007270) | 4.06573175 |
| 42 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.06047450 |
| 43 | postsynaptic membrane organization (GO:0001941) | 3.96950041 |
| 44 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.94345590 |
| 45 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.90857398 |
| 46 | positive regulation of synapse maturation (GO:0090129) | 3.89792145 |
| 47 | gamma-aminobutyric acid transport (GO:0015812) | 3.89532142 |
| 48 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.89128046 |
| 49 | cellular sodium ion homeostasis (GO:0006883) | 3.84129100 |
| 50 | regulation of postsynaptic membrane potential (GO:0060078) | 3.81863434 |
| 51 | * regulation of synaptic plasticity (GO:0048167) | 3.75193625 |
| 52 | cellular potassium ion homeostasis (GO:0030007) | 3.73870568 |
| 53 | neuromuscular process controlling balance (GO:0050885) | 3.73212046 |
| 54 | proline transport (GO:0015824) | 3.65170931 |
| 55 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.62512268 |
| 56 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.62290615 |
| 57 | activation of protein kinase A activity (GO:0034199) | 3.59866042 |
| 58 | transmission of nerve impulse (GO:0019226) | 3.58748005 |
| 59 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.55365006 |
| 60 | * neurotransmitter transport (GO:0006836) | 3.54273924 |
| 61 | prepulse inhibition (GO:0060134) | 3.53886855 |
| 62 | auditory behavior (GO:0031223) | 3.52558089 |
| 63 | long-term synaptic potentiation (GO:0060291) | 3.49921574 |
| 64 | sodium ion export (GO:0071436) | 3.48825555 |
| 65 | regulation of vesicle fusion (GO:0031338) | 3.47409905 |
| 66 | neurotransmitter uptake (GO:0001504) | 3.47407491 |
| 67 | positive regulation of neurotransmitter transport (GO:0051590) | 3.46693770 |
| 68 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.45775425 |
| 69 | regulation of neurotransmitter secretion (GO:0046928) | 3.44809237 |
| 70 | regulation of neurotransmitter levels (GO:0001505) | 3.43686377 |
| 71 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.42957108 |
| 72 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.42855518 |
| 73 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.41167687 |
| 74 | dendritic spine organization (GO:0097061) | 3.38364092 |
| 75 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.37624714 |
| 76 | synaptic vesicle endocytosis (GO:0048488) | 3.32601733 |
| 77 | acidic amino acid transport (GO:0015800) | 3.32302935 |
| 78 | neuromuscular process controlling posture (GO:0050884) | 3.29131663 |
| 79 | cell differentiation in hindbrain (GO:0021533) | 3.27005101 |
| 80 | neuronal ion channel clustering (GO:0045161) | 3.26681466 |
| 81 | membrane depolarization (GO:0051899) | 3.26338239 |
| 82 | regulation of neurotransmitter transport (GO:0051588) | 3.25978888 |
| 83 | positive regulation of dendritic spine development (GO:0060999) | 3.25780813 |
| 84 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.24843128 |
| 85 | response to auditory stimulus (GO:0010996) | 3.24797885 |
| 86 | glycine transport (GO:0015816) | 3.24500030 |
| 87 | neuron recognition (GO:0008038) | 3.23439029 |
| 88 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.23412094 |
| 89 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.22217293 |
| 90 | neuromuscular synaptic transmission (GO:0007274) | 3.22191437 |
| 91 | regulation of dendritic spine development (GO:0060998) | 3.20240326 |
| 92 | cerebellar Purkinje cell layer development (GO:0021680) | 3.17962431 |
| 93 | behavioral fear response (GO:0001662) | 3.17300865 |
| 94 | behavioral defense response (GO:0002209) | 3.17300865 |
| 95 | learning (GO:0007612) | 3.16439434 |
| 96 | chemosensory behavior (GO:0007635) | 3.15822442 |
| 97 | membrane hyperpolarization (GO:0060081) | 3.14664500 |
| 98 | membrane depolarization during action potential (GO:0086010) | 3.13284727 |
| 99 | detection of calcium ion (GO:0005513) | 3.13247102 |
| 100 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.10917709 |
| 101 | regulation of ARF protein signal transduction (GO:0032012) | 3.10346925 |
| 102 | positive regulation of synaptic transmission (GO:0050806) | 3.09512077 |
| 103 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.09362296 |
| 104 | cell communication by electrical coupling (GO:0010644) | 3.09227198 |
| 105 | signal release (GO:0023061) | 3.08883015 |
| 106 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.07380875 |
| 107 | social behavior (GO:0035176) | 3.07166735 |
| 108 | intraspecies interaction between organisms (GO:0051703) | 3.07166735 |
| 109 | fear response (GO:0042596) | 3.06967268 |
| 110 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.05622768 |
| 111 | neuromuscular process (GO:0050905) | 3.05001619 |
| 112 | cell communication involved in cardiac conduction (GO:0086065) | 3.04433990 |
| 113 | positive regulation of vesicle fusion (GO:0031340) | 3.03281472 |
| 114 | * regulation of synaptic transmission (GO:0050804) | 3.02985984 |
| 115 | behavioral response to cocaine (GO:0048148) | 3.02245994 |
| 116 | dendrite morphogenesis (GO:0048813) | 3.01809598 |
| 117 | positive regulation of dendrite development (GO:1900006) | 3.01110858 |
| 118 | mating behavior (GO:0007617) | 3.00738594 |
| 119 | dicarboxylic acid transport (GO:0006835) | 3.00157022 |
| 120 | synaptic transmission (GO:0007268) | 2.99209917 |
| 121 | vesicle transport along microtubule (GO:0047496) | 2.98729811 |
| 122 | * regulation of exocytosis (GO:0017157) | 2.98208061 |
| 123 | regulation of female receptivity (GO:0045924) | 2.98057342 |
| 124 | innervation (GO:0060384) | 2.97778797 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.52331612 |
| 2 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.19068824 |
| 3 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.16025975 |
| 4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.14884152 |
| 5 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.09318861 |
| 6 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 3.03322850 |
| 7 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.88861207 |
| 8 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.82471901 |
| 9 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.82471901 |
| 10 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.77854030 |
| 11 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.73745199 |
| 12 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.66087239 |
| 13 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.63954181 |
| 14 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.63647789 |
| 15 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.62389739 |
| 16 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.54071529 |
| 17 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.52925579 |
| 18 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.51167298 |
| 19 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.37549399 |
| 20 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.35480899 |
| 21 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.34168875 |
| 22 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.33994651 |
| 23 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.33039663 |
| 24 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.25051718 |
| 25 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.20172000 |
| 26 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.12714805 |
| 27 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.04238822 |
| 28 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.88632621 |
| 29 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.76793109 |
| 30 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.76748520 |
| 31 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.74168947 |
| 32 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.59832131 |
| 33 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.54106336 |
| 34 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.54021750 |
| 35 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.53038907 |
| 36 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.40774418 |
| 37 | * CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.39991023 |
| 38 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.36800434 |
| 39 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.36617039 |
| 40 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.35490981 |
| 41 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.29923026 |
| 42 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.26838139 |
| 43 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.26624950 |
| 44 | KDM2B_26808549_Chip-Seq_K562_Human | 1.26449492 |
| 45 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.26213902 |
| 46 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.25438596 |
| 47 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.23669023 |
| 48 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.23335505 |
| 49 | * AR_19668381_ChIP-Seq_PC3_Human | 1.22402476 |
| 50 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.21474075 |
| 51 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.19087395 |
| 52 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.18565052 |
| 53 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.18542864 |
| 54 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.18040999 |
| 55 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.17195484 |
| 56 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.17163714 |
| 57 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.16714952 |
| 58 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.15833171 |
| 59 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.15262947 |
| 60 | P300_19829295_ChIP-Seq_ESCs_Human | 1.14945058 |
| 61 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.14455045 |
| 62 | AR_25329375_ChIP-Seq_VCAP_Human | 1.13801991 |
| 63 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.12429096 |
| 64 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.11956930 |
| 65 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.11671366 |
| 66 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.10014041 |
| 67 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.08970668 |
| 68 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.05595412 |
| 69 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.04858523 |
| 70 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.04054893 |
| 71 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.03772041 |
| 72 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.03661421 |
| 73 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.03480866 |
| 74 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.03456978 |
| 75 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.02856528 |
| 76 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.02820718 |
| 77 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.02780867 |
| 78 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.01697342 |
| 79 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.01066762 |
| 80 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.00871705 |
| 81 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.00737235 |
| 82 | OCT4_19829295_ChIP-Seq_ESCs_Human | 1.00715144 |
| 83 | TCF4_23295773_ChIP-Seq_U87_Human | 1.00399238 |
| 84 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.98566986 |
| 85 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.97877724 |
| 86 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.96698248 |
| 87 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.96332047 |
| 88 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.96301177 |
| 89 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.95929955 |
| 90 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.95910511 |
| 91 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.95399291 |
| 92 | * DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.95214920 |
| 93 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.95017495 |
| 94 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.94380663 |
| 95 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.92944626 |
| 96 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.92389046 |
| 97 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.92190404 |
| 98 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.91191656 |
| 99 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.91160945 |
| 100 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.91084757 |
| 101 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.89903366 |
| 102 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.89626774 |
| 103 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.89020145 |
| 104 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.88787749 |
| 105 | * ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.88588212 |
| 106 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.88534430 |
| 107 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.88463072 |
| 108 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.88319518 |
| 109 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.87916040 |
| 110 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.87570753 |
| 111 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.86507455 |
| 112 | * DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.86418172 |
| 113 | * SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.86319483 |
| 114 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.86169760 |
| 115 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.85896185 |
| 116 | TP53_16413492_ChIP-PET_HCT116_Human | 0.85803145 |
| 117 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.85110976 |
| 118 | RXR_22108803_ChIP-Seq_LS180_Human | 0.84237833 |
| 119 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.84001421 |
| 120 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.82078408 |
| 121 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.81930230 |
| 122 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.80935399 |
| 123 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.79928026 |
| 124 | SMAD4_21741376_ChIP-Seq_ESCs_Human | 0.79652508 |
| 125 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.78900939 |
| 126 | RUNX1_26923725_Chip-Seq_HPCs_Mouse | 0.77896807 |
| 127 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.77331601 |
| 128 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.74248390 |
| 129 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.71077969 |
| 130 | P68_20966046_ChIP-Seq_HELA_Human | 0.70938247 |
| 131 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.70837197 |
| 132 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.70272411 |
| 133 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.69993610 |
| 134 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 0.67863004 |
| 135 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.67471239 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 7.16536235 |
| 2 | MP0002822_catalepsy | 4.45659573 |
| 3 | MP0003880_abnormal_central_pattern | 4.35655641 |
| 4 | * MP0003635_abnormal_synaptic_transmissio | 4.35007537 |
| 5 | MP0004270_analgesia | 3.79741609 |
| 6 | MP0009745_abnormal_behavioral_response | 3.61215196 |
| 7 | * MP0002063_abnormal_learning/memory/cond | 3.44451971 |
| 8 | MP0002064_seizures | 3.24608122 |
| 9 | MP0009046_muscle_twitch | 3.05548502 |
| 10 | * MP0002572_abnormal_emotion/affect_behav | 2.83467496 |
| 11 | MP0001968_abnormal_touch/_nociception | 2.69297287 |
| 12 | MP0002272_abnormal_nervous_system | 2.64715908 |
| 13 | MP0001486_abnormal_startle_reflex | 2.57135105 |
| 14 | MP0002734_abnormal_mechanical_nocicepti | 2.56198246 |
| 15 | MP0005423_abnormal_somatic_nervous | 2.49638208 |
| 16 | MP0001501_abnormal_sleep_pattern | 2.38667100 |
| 17 | MP0002909_abnormal_adrenal_gland | 2.20770295 |
| 18 | MP0009780_abnormal_chondrocyte_physiolo | 2.16642826 |
| 19 | MP0002735_abnormal_chemical_nociception | 2.08566504 |
| 20 | MP0008569_lethality_at_weaning | 2.07351473 |
| 21 | MP0002733_abnormal_thermal_nociception | 1.99649877 |
| 22 | MP0001970_abnormal_pain_threshold | 1.96117392 |
| 23 | MP0002736_abnormal_nociception_after | 1.94073705 |
| 24 | MP0002067_abnormal_sensory_capabilities | 1.83045654 |
| 25 | MP0004811_abnormal_neuron_physiology | 1.81623231 |
| 26 | * MP0001440_abnormal_grooming_behavior | 1.78092903 |
| 27 | MP0002557_abnormal_social/conspecific_i | 1.77500375 |
| 28 | MP0005386_behavior/neurological_phenoty | 1.74985518 |
| 29 | MP0004924_abnormal_behavior | 1.74985518 |
| 30 | MP0002184_abnormal_innervation | 1.71823251 |
| 31 | MP0005646_abnormal_pituitary_gland | 1.71793620 |
| 32 | MP0003329_amyloid_beta_deposits | 1.71607444 |
| 33 | MP0003123_paternal_imprinting | 1.71157794 |
| 34 | MP0003879_abnormal_hair_cell | 1.68181232 |
| 35 | MP0004858_abnormal_nervous_system | 1.66261999 |
| 36 | MP0000955_abnormal_spinal_cord | 1.51739802 |
| 37 | MP0000778_abnormal_nervous_system | 1.49897862 |
| 38 | MP0004885_abnormal_endolymph | 1.46786811 |
| 39 | MP0001984_abnormal_olfaction | 1.42236245 |
| 40 | * MP0002066_abnormal_motor_capabilities/c | 1.40331475 |
| 41 | MP0003633_abnormal_nervous_system | 1.39772387 |
| 42 | MP0002882_abnormal_neuron_morphology | 1.36477639 |
| 43 | MP0001529_abnormal_vocalization | 1.36256711 |
| 44 | MP0003787_abnormal_imprinting | 1.33736314 |
| 45 | MP0006276_abnormal_autonomic_nervous | 1.30259732 |
| 46 | MP0001905_abnormal_dopamine_level | 1.27144268 |
| 47 | MP0005645_abnormal_hypothalamus_physiol | 1.26738884 |
| 48 | MP0001502_abnormal_circadian_rhythm | 1.25307416 |
| 49 | MP0000013_abnormal_adipose_tissue | 1.23268809 |
| 50 | MP0010386_abnormal_urinary_bladder | 1.19122823 |
| 51 | MP0003283_abnormal_digestive_organ | 1.14937330 |
| 52 | MP0003631_nervous_system_phenotype | 1.14608602 |
| 53 | MP0001188_hyperpigmentation | 1.14190956 |
| 54 | MP0003075_altered_response_to | 1.10519407 |
| 55 | MP0008872_abnormal_physiological_respon | 1.08858732 |
| 56 | MP0002152_abnormal_brain_morphology | 1.06246663 |
| 57 | MP0004142_abnormal_muscle_tone | 1.04466240 |
| 58 | MP0004147_increased_porphyrin_level | 1.02843550 |
| 59 | MP0008874_decreased_physiological_sensi | 1.00735182 |
| 60 | MP0001348_abnormal_lacrimal_gland | 1.00453092 |
| 61 | MP0008961_abnormal_basal_metabolism | 1.00429530 |
| 62 | MP0002069_abnormal_eating/drinking_beha | 0.99702643 |
| 63 | MP0005535_abnormal_body_temperature | 0.95747557 |
| 64 | MP0001177_atelectasis | 0.94465863 |
| 65 | MP0003122_maternal_imprinting | 0.91786404 |
| 66 | MP0005409_darkened_coat_color | 0.90060454 |
| 67 | MP0004145_abnormal_muscle_electrophysio | 0.89785489 |
| 68 | MP0002229_neurodegeneration | 0.88826188 |
| 69 | MP0004085_abnormal_heartbeat | 0.88348518 |
| 70 | MP0002837_dystrophic_cardiac_calcinosis | 0.85482320 |
| 71 | MP0001346_abnormal_lacrimal_gland | 0.85460231 |
| 72 | MP0002638_abnormal_pupillary_reflex | 0.83725278 |
| 73 | MP0000569_abnormal_digit_pigmentation | 0.82762719 |
| 74 | MP0005394_taste/olfaction_phenotype | 0.81421051 |
| 75 | MP0005499_abnormal_olfactory_system | 0.81421051 |
| 76 | MP0005551_abnormal_eye_electrophysiolog | 0.81222943 |
| 77 | MP0003632_abnormal_nervous_system | 0.78033230 |
| 78 | MP0000751_myopathy | 0.77438685 |
| 79 | MP0010234_abnormal_vibrissa_follicle | 0.77272342 |
| 80 | MP0004043_abnormal_pH_regulation | 0.74991726 |
| 81 | MP0005167_abnormal_blood-brain_barrier | 0.74533912 |
| 82 | MP0003634_abnormal_glial_cell | 0.74471006 |
| 83 | MP0002090_abnormal_vision | 0.74304905 |
| 84 | MP0003690_abnormal_glial_cell | 0.73783372 |
| 85 | MP0000631_abnormal_neuroendocrine_gland | 0.73377947 |
| 86 | MP0004742_abnormal_vestibular_system | 0.72331285 |
| 87 | MP0000604_amyloidosis | 0.70847330 |
| 88 | MP0008877_abnormal_DNA_methylation | 0.70799402 |
| 89 | MP0001986_abnormal_taste_sensitivity | 0.69576847 |
| 90 | MP0000920_abnormal_myelination | 0.68777233 |
| 91 | MP0001963_abnormal_hearing_physiology | 0.68501684 |
| 92 | MP0005623_abnormal_meninges_morphology | 0.68311050 |
| 93 | MP0001664_abnormal_digestion | 0.62102358 |
| 94 | MP0002752_abnormal_somatic_nervous | 0.62076614 |
| 95 | MP0004215_abnormal_myocardial_fiber | 0.61698054 |
| 96 | MP0004510_myositis | 0.61574787 |
| 97 | MP0003172_abnormal_lysosome_physiology | 0.61098603 |
| 98 | MP0003121_genomic_imprinting | 0.59090346 |
| 99 | MP0004484_altered_response_of | 0.56970918 |
| 100 | MP0005187_abnormal_penis_morphology | 0.56752295 |
| 101 | MP0004130_abnormal_muscle_cell | 0.56607806 |
| 102 | MP0000579_abnormal_nail_morphology | 0.56471881 |
| 103 | MP0003137_abnormal_impulse_conducting | 0.56350843 |
| 104 | MP0001485_abnormal_pinna_reflex | 0.56246679 |
| 105 | MP0002234_abnormal_pharynx_morphology | 0.55377417 |
| 106 | MP0010768_mortality/aging | 0.53863698 |
| 107 | MP0002082_postnatal_lethality | 0.52948215 |
| 108 | MP0001943_abnormal_respiration | 0.50938532 |
| 109 | MP0010769_abnormal_survival | 0.50803936 |
| 110 | MP0003956_abnormal_body_size | 0.50306578 |
| 111 | MP0002876_abnormal_thyroid_physiology | 0.47875225 |
| 112 | MP0010770_preweaning_lethality | 0.47601626 |
| 113 | MP0003861_abnormal_nervous_system | 0.46680097 |
| 114 | MP0000639_abnormal_adrenal_gland | 0.46626295 |
| 115 | MP0001765_abnormal_ion_homeostasis | 0.44226420 |
| 116 | MP0005166_decreased_susceptibility_to | 0.43868633 |
| 117 | MP0001731_abnormal_postnatal_growth | 0.43318183 |
| 118 | MP0001299_abnormal_eye_distance/ | 0.43084403 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 8.11452668 |
| 2 | Myokymia (HP:0002411) | 7.90873349 |
| 3 | Focal seizures (HP:0007359) | 5.96670927 |
| 4 | Visual hallucinations (HP:0002367) | 5.82093078 |
| 5 | Epileptic encephalopathy (HP:0200134) | 4.56337606 |
| 6 | Action tremor (HP:0002345) | 4.53576064 |
| 7 | Atonic seizures (HP:0010819) | 4.38870944 |
| 8 | Progressive cerebellar ataxia (HP:0002073) | 4.38275227 |
| 9 | Febrile seizures (HP:0002373) | 4.30435280 |
| 10 | Absence seizures (HP:0002121) | 4.05783238 |
| 11 | Generalized tonic-clonic seizures (HP:0002069) | 3.86315660 |
| 12 | Dialeptic seizures (HP:0011146) | 3.77744881 |
| 13 | Tetraplegia (HP:0002445) | 3.71985264 |
| 14 | Poor eye contact (HP:0000817) | 3.64666075 |
| 15 | Cerebral hypomyelination (HP:0006808) | 3.63145470 |
| 16 | Depression (HP:0000716) | 3.59475973 |
| 17 | Gaze-evoked nystagmus (HP:0000640) | 3.58807279 |
| 18 | Broad-based gait (HP:0002136) | 3.54001658 |
| 19 | Papilledema (HP:0001085) | 3.53554748 |
| 20 | Ankle clonus (HP:0011448) | 3.46152917 |
| 21 | Anxiety (HP:0000739) | 3.44170386 |
| 22 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.43403403 |
| 23 | Supranuclear gaze palsy (HP:0000605) | 3.40797048 |
| 24 | Dysdiadochokinesis (HP:0002075) | 3.31512778 |
| 25 | Abnormal social behavior (HP:0012433) | 3.31011283 |
| 26 | Impaired social interactions (HP:0000735) | 3.31011283 |
| 27 | Dysmetria (HP:0001310) | 3.14270138 |
| 28 | Truncal ataxia (HP:0002078) | 3.12940943 |
| 29 | Amblyopia (HP:0000646) | 3.11684446 |
| 30 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.05550783 |
| 31 | Akinesia (HP:0002304) | 3.01516895 |
| 32 | Postural instability (HP:0002172) | 3.00236489 |
| 33 | Impaired smooth pursuit (HP:0007772) | 3.00099471 |
| 34 | Hyperventilation (HP:0002883) | 2.96136337 |
| 35 | Torticollis (HP:0000473) | 2.95153982 |
| 36 | Abnormality of the lower motor neuron (HP:0002366) | 2.88467341 |
| 37 | Annular pancreas (HP:0001734) | 2.88435862 |
| 38 | Focal dystonia (HP:0004373) | 2.81622611 |
| 39 | Abnormal eating behavior (HP:0100738) | 2.75149330 |
| 40 | Genetic anticipation (HP:0003743) | 2.73991517 |
| 41 | Stereotypic behavior (HP:0000733) | 2.72635733 |
| 42 | Mutism (HP:0002300) | 2.69192607 |
| 43 | Intention tremor (HP:0002080) | 2.68625138 |
| 44 | Hemiparesis (HP:0001269) | 2.64382610 |
| 45 | Scanning speech (HP:0002168) | 2.62512303 |
| 46 | Ventricular fibrillation (HP:0001663) | 2.61037018 |
| 47 | Hemiplegia (HP:0002301) | 2.60856132 |
| 48 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.58602453 |
| 49 | Urinary urgency (HP:0000012) | 2.56132753 |
| 50 | Bradykinesia (HP:0002067) | 2.55658849 |
| 51 | Spastic gait (HP:0002064) | 2.53327482 |
| 52 | Dysmetric saccades (HP:0000641) | 2.52148645 |
| 53 | Megalencephaly (HP:0001355) | 2.52100300 |
| 54 | Sleep apnea (HP:0010535) | 2.51581687 |
| 55 | Epileptiform EEG discharges (HP:0011182) | 2.47847927 |
| 56 | Craniofacial dystonia (HP:0012179) | 2.47234086 |
| 57 | Spastic tetraparesis (HP:0001285) | 2.47090390 |
| 58 | Cerebral inclusion bodies (HP:0100314) | 2.45873252 |
| 59 | Abnormality of binocular vision (HP:0011514) | 2.42379005 |
| 60 | Diplopia (HP:0000651) | 2.42379005 |
| 61 | Progressive inability to walk (HP:0002505) | 2.42346002 |
| 62 | EEG with generalized epileptiform discharges (HP:0011198) | 2.42127480 |
| 63 | Drooling (HP:0002307) | 2.41868814 |
| 64 | Excessive salivation (HP:0003781) | 2.41868814 |
| 65 | Peripheral hypomyelination (HP:0007182) | 2.40932346 |
| 66 | Pointed chin (HP:0000307) | 2.39065114 |
| 67 | Choreoathetosis (HP:0001266) | 2.38760940 |
| 68 | Resting tremor (HP:0002322) | 2.37718307 |
| 69 | Hypsarrhythmia (HP:0002521) | 2.34582569 |
| 70 | Impaired vibratory sensation (HP:0002495) | 2.33466953 |
| 71 | Limb dystonia (HP:0002451) | 2.33201248 |
| 72 | Neurofibrillary tangles (HP:0002185) | 2.32326688 |
| 73 | Diminished motivation (HP:0000745) | 2.31923050 |
| 74 | CNS hypomyelination (HP:0003429) | 2.25049027 |
| 75 | Ankyloglossia (HP:0010296) | 2.24671193 |
| 76 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.24022679 |
| 77 | Absent speech (HP:0001344) | 2.21533526 |
| 78 | Status epilepticus (HP:0002133) | 2.21186717 |
| 79 | Agitation (HP:0000713) | 2.20994769 |
| 80 | Obstructive sleep apnea (HP:0002870) | 2.15231830 |
| 81 | Bundle branch block (HP:0011710) | 2.15157031 |
| 82 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.07057197 |
| 83 | Gait ataxia (HP:0002066) | 2.05748743 |
| 84 | Lower limb asymmetry (HP:0100559) | 2.05706609 |
| 85 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.04104099 |
| 86 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.04104099 |
| 87 | Generalized myoclonic seizures (HP:0002123) | 2.03061296 |
| 88 | Insidious onset (HP:0003587) | 2.02480312 |
| 89 | Termporal pattern (HP:0011008) | 2.02480312 |
| 90 | Fetal akinesia sequence (HP:0001989) | 2.00111446 |
| 91 | Increased circulating renin level (HP:0000848) | 1.99885978 |
| 92 | Insomnia (HP:0100785) | 1.99070695 |
| 93 | Incomplete penetrance (HP:0003829) | 1.98452300 |
| 94 | Lower limb muscle weakness (HP:0007340) | 1.97627693 |
| 95 | Abnormal EKG (HP:0003115) | 1.97449363 |
| 96 | Clonus (HP:0002169) | 1.92016184 |
| 97 | Pheochromocytoma (HP:0002666) | 1.91002975 |
| 98 | Polyphagia (HP:0002591) | 1.87240975 |
| 99 | Delusions (HP:0000746) | 1.86240077 |
| 100 | Rigidity (HP:0002063) | 1.84740093 |
| 101 | Inability to walk (HP:0002540) | 1.84088475 |
| 102 | Psychosis (HP:0000709) | 1.82276794 |
| 103 | Neuronal loss in central nervous system (HP:0002529) | 1.81698258 |
| 104 | Bronchomalacia (HP:0002780) | 1.81181240 |
| 105 | Memory impairment (HP:0002354) | 1.80872485 |
| 106 | Rapidly progressive (HP:0003678) | 1.80637014 |
| 107 | Abnormality of saccadic eye movements (HP:0000570) | 1.80170611 |
| 108 | Spinal canal stenosis (HP:0003416) | 1.79997068 |
| 109 | Amyotrophic lateral sclerosis (HP:0007354) | 1.79203940 |
| 110 | Lower limb amyotrophy (HP:0007210) | 1.78593963 |
| 111 | Prolonged QT interval (HP:0001657) | 1.77396050 |
| 112 | Aplasia involving bones of the extremities (HP:0009825) | 1.76847352 |
| 113 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.76847352 |
| 114 | Aplasia of the phalanges of the hand (HP:0009802) | 1.76847352 |
| 115 | Abnormality of the corticospinal tract (HP:0002492) | 1.76759702 |
| 116 | Postural tremor (HP:0002174) | 1.76476205 |
| 117 | Hand muscle atrophy (HP:0009130) | 1.76434104 |
| 118 | Unsteady gait (HP:0002317) | 1.75289858 |
| 119 | Apathy (HP:0000741) | 1.73478461 |
| 120 | Blue irides (HP:0000635) | 1.73325680 |
| 121 | Abnormality of the periventricular white matter (HP:0002518) | 1.71464627 |
| 122 | Heart block (HP:0012722) | 1.70915295 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 5.10256875 |
| 2 | NTRK3 | 4.77325780 |
| 3 | MAP3K9 | 3.83829159 |
| 4 | MAP3K4 | 2.75917914 |
| 5 | DAPK2 | 2.74302896 |
| 6 | PRKD3 | 2.65408865 |
| 7 | MINK1 | 2.63284594 |
| 8 | KSR2 | 2.48535214 |
| 9 | MARK1 | 2.33148487 |
| 10 | MAP2K7 | 2.25594066 |
| 11 | CAMKK1 | 2.22473008 |
| 12 | PAK6 | 2.20878902 |
| 13 | RIPK4 | 2.18572711 |
| 14 | NTRK1 | 2.13830348 |
| 15 | NTRK2 | 1.94484549 |
| 16 | MAP2K4 | 1.68839884 |
| 17 | KSR1 | 1.68566699 |
| 18 | DAPK1 | 1.65310956 |
| 19 | ARAF | 1.64196905 |
| 20 | CDK5 | 1.61530306 |
| 21 | FES | 1.56518548 |
| 22 | MAP3K2 | 1.51776129 |
| 23 | MAP3K13 | 1.49132612 |
| 24 | TNIK | 1.44761290 |
| 25 | MAP3K12 | 1.44664724 |
| 26 | GRK5 | 1.42898905 |
| 27 | SIK2 | 1.40792876 |
| 28 | CAMKK2 | 1.39398573 |
| 29 | STK38 | 1.38910754 |
| 30 | PRPF4B | 1.36821277 |
| 31 | PNCK | 1.32588559 |
| 32 | PRKCG | 1.19288570 |
| 33 | PLK2 | 1.17534439 |
| 34 | TYRO3 | 1.16896353 |
| 35 | UHMK1 | 1.16168321 |
| 36 | TAOK1 | 1.11716672 |
| 37 | CAMK1 | 1.08576256 |
| 38 | MAPK13 | 1.04520407 |
| 39 | CDK19 | 1.02475781 |
| 40 | PRKCH | 1.00720772 |
| 41 | RAF1 | 0.99055806 |
| 42 | CAMK2A | 0.92281100 |
| 43 | STK11 | 0.91256335 |
| 44 | SGK223 | 0.89358288 |
| 45 | SGK494 | 0.89358288 |
| 46 | PTK2B | 0.88266666 |
| 47 | BMPR2 | 0.87531037 |
| 48 | RET | 0.86703179 |
| 49 | CASK | 0.85792794 |
| 50 | CDK18 | 0.85756324 |
| 51 | CDK15 | 0.85394405 |
| 52 | MAP3K1 | 0.84595190 |
| 53 | CDK14 | 0.82452309 |
| 54 | PINK1 | 0.81404728 |
| 55 | ALK | 0.81183577 |
| 56 | CAMK2B | 0.79025656 |
| 57 | MAPK12 | 0.78618799 |
| 58 | SGK2 | 0.75243436 |
| 59 | CDK11A | 0.75015343 |
| 60 | PDK1 | 0.73415828 |
| 61 | MARK2 | 0.72445885 |
| 62 | LIMK1 | 0.71882356 |
| 63 | SGK1 | 0.71281797 |
| 64 | SGK3 | 0.70881762 |
| 65 | DYRK1A | 0.68260070 |
| 66 | PDPK1 | 0.67658850 |
| 67 | PKN1 | 0.67080364 |
| 68 | RIPK1 | 0.65483072 |
| 69 | PAK3 | 0.64068088 |
| 70 | MAP3K11 | 0.61685477 |
| 71 | PHKG2 | 0.60358201 |
| 72 | PHKG1 | 0.60358201 |
| 73 | BRAF | 0.59659086 |
| 74 | LMTK2 | 0.59648468 |
| 75 | FGFR2 | 0.58638193 |
| 76 | LATS2 | 0.57625511 |
| 77 | CSNK1G2 | 0.56894989 |
| 78 | BRSK1 | 0.54885616 |
| 79 | MAP2K1 | 0.53152370 |
| 80 | TNK2 | 0.52085978 |
| 81 | SCYL2 | 0.51750104 |
| 82 | RPS6KA3 | 0.51744108 |
| 83 | CAMK4 | 0.51476953 |
| 84 | TESK1 | 0.51247088 |
| 85 | CDC42BPA | 0.49632067 |
| 86 | FYN | 0.48060974 |
| 87 | WNK1 | 0.47450194 |
| 88 | ROCK2 | 0.47045454 |
| 89 | PRKCZ | 0.47000441 |
| 90 | NEK6 | 0.44734706 |
| 91 | CAMK2D | 0.44292706 |
| 92 | PRKCE | 0.44017408 |
| 93 | MAPK10 | 0.43889593 |
| 94 | MAP3K7 | 0.43665170 |
| 95 | CAMK1G | 0.43463147 |
| 96 | PRKD2 | 0.43361214 |
| 97 | DAPK3 | 0.40331436 |
| 98 | WNK3 | 0.39831720 |
| 99 | CAMK2G | 0.39130372 |
| 100 | FGR | 0.38849392 |
| 101 | OXSR1 | 0.37701574 |
| 102 | FER | 0.36714954 |
| 103 | PRKG2 | 0.36611233 |
| 104 | NEK1 | 0.36108220 |
| 105 | IRAK2 | 0.36103680 |
| 106 | NME1 | 0.33972579 |
| 107 | DMPK | 0.33192387 |
| 108 | PRKCB | 0.32334254 |
| 109 | PRKCA | 0.32224918 |
| 110 | ERBB2 | 0.31958046 |
| 111 | MUSK | 0.30164012 |
| 112 | HIPK2 | 0.30079518 |
| 113 | MAPKAPK5 | 0.29143646 |
| 114 | MAP2K6 | 0.27901075 |
| 115 | ROCK1 | 0.27667206 |
| 116 | MAPK8 | 0.27044099 |
| 117 | SRC | 0.25368831 |
| 118 | CCNB1 | 0.23977319 |
| 119 | CSNK1E | 0.23246106 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.33024561 |
| 2 | * Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.03566827 |
| 3 | Olfactory transduction_Homo sapiens_hsa04740 | 2.99423708 |
| 4 | Long-term potentiation_Homo sapiens_hsa04720 | 2.81071926 |
| 5 | Circadian entrainment_Homo sapiens_hsa04713 | 2.75781176 |
| 6 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.68583398 |
| 7 | GABAergic synapse_Homo sapiens_hsa04727 | 2.62219395 |
| 8 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.62205961 |
| 9 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.58427851 |
| 10 | Morphine addiction_Homo sapiens_hsa05032 | 2.51248385 |
| 11 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.28573039 |
| 12 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.24418426 |
| 13 | Insulin secretion_Homo sapiens_hsa04911 | 2.22287462 |
| 14 | Salivary secretion_Homo sapiens_hsa04970 | 2.18683420 |
| 15 | Cholinergic synapse_Homo sapiens_hsa04725 | 2.09963064 |
| 16 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 2.02584616 |
| 17 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.96420653 |
| 18 | Cocaine addiction_Homo sapiens_hsa05030 | 1.89298979 |
| 19 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.85202474 |
| 20 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.72183504 |
| 21 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.71613265 |
| 22 | Renin secretion_Homo sapiens_hsa04924 | 1.71060926 |
| 23 | Long-term depression_Homo sapiens_hsa04730 | 1.70560265 |
| 24 | Taste transduction_Homo sapiens_hsa04742 | 1.69308584 |
| 25 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.65283192 |
| 26 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.63394819 |
| 27 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.53453204 |
| 28 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.45028352 |
| 29 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.38049311 |
| 30 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.37529327 |
| 31 | Gap junction_Homo sapiens_hsa04540 | 1.36376674 |
| 32 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.35552445 |
| 33 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.32085494 |
| 34 | Glioma_Homo sapiens_hsa05214 | 1.24103797 |
| 35 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.22612102 |
| 36 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.20646275 |
| 37 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.19058382 |
| 38 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.16464393 |
| 39 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.10569040 |
| 40 | Melanogenesis_Homo sapiens_hsa04916 | 1.06043626 |
| 41 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.05470299 |
| 42 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.99478794 |
| 43 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.99344408 |
| 44 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.98327840 |
| 45 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.92721866 |
| 46 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.92454113 |
| 47 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.91646448 |
| 48 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.89739461 |
| 49 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.89041706 |
| 50 | Axon guidance_Homo sapiens_hsa04360 | 0.89018152 |
| 51 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.88315709 |
| 52 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.86744573 |
| 53 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.86136508 |
| 54 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.84106394 |
| 55 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.81497271 |
| 56 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.77763929 |
| 57 | Phototransduction_Homo sapiens_hsa04744 | 0.76897379 |
| 58 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.76477894 |
| 59 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.76157188 |
| 60 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.73786403 |
| 61 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.71496926 |
| 62 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.71239916 |
| 63 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.70375097 |
| 64 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.67669745 |
| 65 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.67468206 |
| 66 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.66259504 |
| 67 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.65829544 |
| 68 | Alcoholism_Homo sapiens_hsa05034 | 0.63624437 |
| 69 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.58888298 |
| 70 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.58454242 |
| 71 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.58006889 |
| 72 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.55630190 |
| 73 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.54569237 |
| 74 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.54308920 |
| 75 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.54086138 |
| 76 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.53991690 |
| 77 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.51528648 |
| 78 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.50992282 |
| 79 | Endocytosis_Homo sapiens_hsa04144 | 0.49322813 |
| 80 | Bile secretion_Homo sapiens_hsa04976 | 0.49153486 |
| 81 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.47574622 |
| 82 | Circadian rhythm_Homo sapiens_hsa04710 | 0.47363213 |
| 83 | Prion diseases_Homo sapiens_hsa05020 | 0.44042389 |
| 84 | Endometrial cancer_Homo sapiens_hsa05213 | 0.43246704 |
| 85 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.42073653 |
| 86 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.41650170 |
| 87 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.41497306 |
| 88 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.40493716 |
| 89 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.40452828 |
| 90 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.39973757 |
| 91 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.39899336 |
| 92 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.38278452 |
| 93 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.37972566 |
| 94 | Mineral absorption_Homo sapiens_hsa04978 | 0.36866643 |
| 95 | Histidine metabolism_Homo sapiens_hsa00340 | 0.36724405 |
| 96 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.34730353 |
| 97 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.34380611 |
| 98 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.33786962 |
| 99 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.32030436 |
| 100 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.31692850 |
| 101 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.29504422 |
| 102 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.27088204 |
| 103 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.26743808 |
| 104 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.26690256 |
| 105 | Platelet activation_Homo sapiens_hsa04611 | 0.26651566 |
| 106 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.26629905 |
| 107 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.25932762 |
| 108 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.25909959 |
| 109 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.25030973 |
| 110 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.24765140 |
| 111 | Alzheimers disease_Homo sapiens_hsa05010 | 0.21117968 |
| 112 | Tight junction_Homo sapiens_hsa04530 | 0.20711895 |
| 113 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.20371945 |
| 114 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.17245793 |
| 115 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.15330437 |

